vVARDIS
vvardis.com
Actively hiring
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$86.8M
3 rounds on record
Latest round
$50M
Venture round · Jul 2025 · 14 mo ago
Team
11-50
employees, estimated range
Backers
1
OrbiMed
The money's age
Due for its next round
14 months since the last round · not hiring
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Jun 13, 2024
Partnership VideaHealth and vVARDIS Team Up, Elevating Preventative Dental Care for Millions · PRNewswire
Nov 30, 2021
Raised a round Venture round $1.8M · SEC Form D
2020
Founded
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Jul 2025 | $50M | — | FinanzNachrichten.de |
| Venture round | Feb 2025 | $35M | — | The Globe and Mail |
| Venture round | Nov 2021 | $1.8M | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | Vardis AG | its site |
Backed byfrom the funds' portfolios and accelerator catalogs
OrbiMed Similar startupsby what they do, their industry and backers
Find an Iswarya IVF & Fertility Centre near you, meet fertility specialists, explore treatment options, and request a confidential…
AI-powered patient monitoring with near real-time waveforms, alarm management, and predictive analytics. Trusted by 675+ hospitals…
Discover how NanoQT builds the foundation for scalable quantum computing with nanofiber cavity-QED technology and high-fidelity quantum…
The first fully autonomous, needle-free glucose sensor. The Biolinq Shine™ sensor is the first glucose sensor with no hypodermic needle for…
Early Stage Startup that is Simplifying Business, One App at a Time.Forget about those overcomplicated, pricey software giants. We.
Tessera Therapeutics is an early-stage life sciences company pioneering Gene Writing™, a new biotechnology designed to offer scientists and…
News
vVARDIS: Apollo Investment Confirms Unicorn Status And Expands Global Dental Medtech Platform
vVARDIS Holding AG announced a strategic minority investment from funds managed by Apollo Global Management, supporting the company's global expansion and establishing it as a billion-dollar-plus healthcare company.
Read more
Report
Report
vVARDIS Founders Present Drill-Free Early Cavity Treatment and Unveil Global Cavity Awareness Campaign at the 2026 J.P. Morgan Healthcare Conference
vVARDIS, a Swiss high-growth healthcare company, active in the development of innovative dental products, today presented its pioneering solution for the tre...
Read more
Report
vVARDIS' Drill-Free Solution Curodont Has Treated Over One Million Teeth in 18 Months and Is the Fastest Growing Dental Care Product in Its Category
vVARDIS' Drill-Free Solution Curodont Has Treated Over One Million Teeth in 18 Months and Is the Fastest Growing Dental Care Product in Its Category
Read more
Report
Pro access
Upgrade to see all 15 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.
People
Florian Randlkofer
Director
Golnar Abivardi-Signer
Director
Gerardus Hoogland
Director
Roberto Rabanal
Director
Giovanni Pieraccioni
Director
Haleh Abivardi-Bronner
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Baar
Switzerland
HQ
10-50 est. staff